Merck Sees Perfect Elixir in China Market Growth

Merck, a Germany-based science and technology giant, has expressed confidence in China's long-term growth prospects. According to Rogier Janssens, president of Merck China, the country's economic resilience is driven by high-end manufacturing, digital economy, and modern services.

The first-half GDP data showed that China's value-added output of high-tech manufacturing rose 13.3 percent year-on-year, while its GDP grew 4.7 percent to 69.57 trillion yuan ($10.3 trillion). Janssens noted that new growth drivers contributed more than 40 percent to the country's economic growth.

Merck has invested nearly 7 billion yuan in China over the past decade and sees it as its second-largest market globally. The company is expanding its high-purity reagent production capacity in Jiangsu province and upgrading its M Lab Collaboration Center in Shanghai.